Publikationen (115) Publikationen von JOSE BLANCO MENDEZ

2021

  1. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  2. Diseño, desarrollo y caracterización de nanopartículas de PLGA cargadas con adalimumab

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 63-65

  3. In vitro development of a new sponge-based delivery system for intracanal antimicrobial administration in endodontic treatment

    Journal of Clinical Medicine, Vol. 10, Núm. 12

  4. Indomethacin microencapsulation in polymeric blends of PLGA502 and PEOT-PBT multiblock copolymer

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 57-59

2020

  1. Sponges containing tetracycline loaded-PLGA-zein microparticles as a periodontal controlled release device

    Journal of Drug Delivery Science and Technology, Vol. 59

2019

  1. Development, characterization, and in vitro evaluation of resveratrol-loaded poly-(ε-caprolactone) microcapsules prepared by ultrasonic atomization for intra-articular administration

    Pharmaceutics, Vol. 11, Núm. 6

  2. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572

  3. Three-Dimensional Hybrid Mesoporous Scaffolds for Simvastatin Sustained Delivery with in Vitro Cell Compatibility

    ACS Omega, Vol. 4, Núm. 3, pp. 5496-5508

2018

  1. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis

    Journal of Pharmaceutical Sciences, Vol. 107, Núm. 5, pp. 1342-1351

  2. Stimuli sensitive ocular drug delivery systems

    Drug Targeting and Stimuli Sensitive Drug Delivery Systems (Elsevier), pp. 211-270

2017

  1. Cellulose-polysaccharide film-coating of cyclodextrin based pellets for controlled drug release

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 273-283

  2. Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 678-687

  3. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging

    International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722

  4. Development and characterization of anti-inflammatory activity of curcumin-loaded biodegradable microspheres with potential use in intestinal inflammatory disorders

    International Journal of Pharmaceutics, Vol. 518, Núm. 1-2, pp. 86-104

  5. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  6. Pharmacokinetic model of florfenicol in turbot (Scophthalmus maximus): establishment of optimal dosage and administration in medicated feed

    Journal of Fish Diseases, Vol. 40, Núm. 3, pp. 411-424

  7. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  8. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy

    European Journal of Pharmaceutical Sciences, Vol. 92, pp. 74-85

  2. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the hospital pharmacy departments

    Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 352-370